Best Grants for Cancer Nonprofits in Northern Mariana Islands

Undergraduate-focused higher education institutions in the Northern Mariana Islands conducting biomedical research, including cancer and oncology projects, can apply for National Institutes of Health Academic Research Enhancement Awards, with awards up to US $375,000. Eligible colleges must award baccalaureate science degrees and have limited prior NIH funding across non-health professional schools.

The National Cancer Institute (NCI) invites research applications focused on early-onset cancers (ages 18-49), aiming to uncover their etiology and biological mechanisms. This funding opportunity supports studies that explore modifiable risk factors, biological responses, and improved identification of at-risk individuals. The initiative seeks to address the concerning rise in these cancers among young adults, facilitating essential prevention and control strategies. Applicants can choose between exploratory or research project formats, with project durations ranging from 2 to 5 years.

The National Cancer Institute's STRIPE program aims to advance cancer therapy by investigating the effects of radionuclide-emitted radiation. This initiative encourages multidisciplinary research to understand how radiation impacts normal tissues and tumor cells, ultimately improving therapeutic outcomes. By consolidating various funding mechanisms, STRIPE seeks to lower entry barriers for researchers, enhance the scientific foundation of radiopharmaceutical therapy, and foster innovative treatment strategies. Projects can be exploratory or research-focused, with flexible timelines for completion.

The Canine Cancer Immunotherapy Network (K9CIN) aims to advance canine cancer treatments through innovative clinical trials, paralleling the development of human therapies. This initiative is vital as pet dogs naturally develop cancer, mirroring human responses to treatments. By leveraging NIH support, K9CIN will facilitate research to enhance immunotherapeutic strategies for both dogs and humans, fostering a collaborative environment for veterinary and human medical advancements. Ultimately, this funding opportunity promotes ethical research that benefits both species.

This funding opportunity aims to bolster the cancer surveillance workforce through educational initiatives. By enhancing collaborations with cancer partners and developing tools for improved data quality, this program will expand the capacity of registrars. Efforts will focus on recruitment and retention, ultimately ensuring compliance with Public Law 102-515. Strengthening the cancer registrar workforce will lead to timely and accurate cancer data submission, supporting public health objectives.

The NCI Pathway to Independence Award (K99/R00) supports early-stage postdoctoral researchers transitioning to independent faculty positions. This funding opportunity encourages talented individuals with clinical or research doctoral degrees to lead independent clinical trials. Applicants should aim to foster research careers in cancer control, prevention, and data sciences. This initiative provides essential support during the transition from mentored positions to independent research roles, enhancing the pool of independent investigators in cancer research.

The NCI Pathway to Independence Award (K99/R00) supports early-stage postdoctoral researchers aiming to transition to independent faculty positions. It encourages candidates with doctoral degrees in research or clinical fields to apply, particularly those in cancer control and prevention. This funding opportunity facilitates a quick shift from mentored research to independent careers, providing essential support for awardees to establish competitive research programs without leading their own clinical trials.

The National Cancer Institute invites applications for the validation of biomarkers and assays for cancer detection and treatment. This funding opportunity supports both analytical and clinical validation of assays, emphasizing the importance of human samples. The program encourages multi-disciplinary collaboration and aims to enhance the performance and reproducibility of cancer assays across clinical laboratories. Applications are due by 5:00 PM local time during the designated deadlines each year.

The Exploratory Grant Award aims to enhance workforce diversity in basic cancer research by supporting junior and Early Stage Investigators from underrepresented groups in the biomedical and social sciences. This initiative provides essential funding to bridge the gap for researchers completing their training, ensuring they have the resources needed to develop larger grant applications. Applications are due by 5:00 PM local time of the applicant organization, emphasizing the importance of timely submissions.

Grants from NIH help Northern Mariana Islands cancer and health equity researchers study how tobacco, alcohol, and cannabis policies affect use and secondhand exposure in populations experiencing disparities. Eligible projects must be U.S.-based, engage community organizations, and can request up to US $275,000 to advance cancer prevention through policy-focused research.

The Cancer Research Education Grants Program (R25) aims to enhance research education in areas crucial to the NIH mission. This program supports innovative courses that develop skills in cancer research, covering topics such as prevention, diagnosis, and treatment. Grant applications are encouraged to be creative and state-of-the-art, addressing the needs of patients and their families. Key deadlines for applications span from January 2024 to September 2026, ensuring ongoing support for educational initiatives.

The Cancer Health Equity Research Centers (CHERCs) initiative by the American Cancer Society aims to address health disparities by supporting research focused on social determinants affecting cancer care. This program encourages innovative projects that engage communities, enhance access, and improve outcomes across diverse populations. By fostering collaborations and promoting multidisciplinary approaches, CHERCs strive to create equitable cancer prevention and treatment solutions, ensuring that all individuals have fair opportunities for cancer care and survivorship.

The Institutional Research Grants (IRG) program by the American Cancer Society provides essential seed funding for newly independent investigators to launch cancer research projects. Aimed at junior faculty, these grants offer $120,000 annually for three years, supporting the development of preliminary results necessary for competing for larger national grants. Eligible applicants must be at US academic institutions and hold the rank of Associate or Full Professor, with a proven track record in research and mentorship.

The American Cancer Society (ACS) and the American Society for Radiation Oncology (ASTRO) co-fund the Clinician Scientist Development Grant (CSDG), aimed at advancing the research careers of clinician scientists in radiation oncology. Eligible applicants are full-time faculty members at U.S. institutions with a doctoral degree and an active clinical license. The grant supports research for 3 to 5 years, providing $135,000 annually for direct costs, plus allowable indirect costs, while encouraging diversity in applications.

The Clinician Scientist Development Grant (CSDG) by the American Cancer Society supports full-time faculty aiming to become independent clinician scientists while maintaining clinical practice. Eligible applicants must hold a doctoral degree, an active clinical license, and have clinical care experience. The grant provides funding of $135,000 annually for 3 to 5 years, including allowable indirect costs, to advance cancer research in key priority areas.

The American Cancer Society's Mentored Research Grants for Postdoctoral Fellowships (PF) aim to support emerging researchers in their training programs, fostering their transition to independent cancer research careers. Eligible candidates include US citizens or non-citizens with valid visas who have completed their doctoral degrees within the last four years. The fellowship offers funding for up to three years, with stipends of $66,000 to $70,000 annually, alongside allowances for health insurance and professional development.

The Mission Boost Grants (MBG) by the American Cancer Society aim to enhance cancer research by funding projects that translate into human testing. These grants support investigators at all levels, offering resources for innovative clinical projects. The program consists of two funding stages: Stage I focuses on developing clear milestones for new treatments, while Stage II supports patient testing, ultimately contributing to advancements in cancer care and treatment.

Postdoctoral cancer researchers from nationally underrepresented backgrounds in the Northern Mariana Islands and other eligible U.S. locations can seek support to transition into independent faculty roles. Focused on cancer and biomedical research careers, the National Institutes of Health’s NCI CURE K22 award provides three years of salary and research support “protected time.”

Postdoctoral fellows and equivalent early-career cancer researchers in the Northern Mariana Islands can seek support to transition into independent, assistant professor–level positions. With a mission to advance biomedical research careers, the National Institutes of Health provides career development funding for oncology and related professional training, offering up to US $150,000 through this K22 award mechanism.

Clinical scientists pursuing mentored cancer research career development can receive support for biomedical, behavioral, or translational oncology projects, including cancer health disparities, in the Northern Mariana Islands and other U.S. jurisdictions. US Dept. of Health & Human Services: National Institutes of Health provides protected time and training through its NCI Continuing Umbrella of Research Experiences (CURE) K08 program.

Focused on cancer and oncology research careers, the National Institutes of Health invites clinical scientists to pursue mentored research development awards supporting biomedical, behavioral, and translational cancer studies. Eligible investigators from underrepresented backgrounds, including those based in the Northern Mariana Islands, receive protected time and training to advance toward independent cancer research funding.

The NCI Worta McCaskill-Stevens Career Development Award supports new clinicians committed to research in community oncology and cancer prevention. This funding aims to facilitate their transition to independent research careers and advanced funding mechanisms. Scholars can lead independent community-based clinical trials, conduct ancillary studies, or gain valuable research experience, specifically targeting underserved communities. Applications are due by 5:00 PM local time of the applicant's organization.

Cancer and health-disparities research institutions in the Northern Mariana Islands can seek funding to develop multi-level interventions addressing disparities in liver diseases and liver cancer. US Dept. of Health & Human Services: National Institutes of Health supports projects serving U.S. populations experiencing health disparities through this R01 opportunity, with multiple standard and renewal deadlines through 2027.

Research institutions and similar organizations conducting advanced pre-clinical work on nanotechnology-based cancer diagnostics or therapeutics in the Northern Mariana Islands can apply for NIH funding, with awards up to US $1,900,000. With a mission to advance cancer treatment, NIH supports projects maturing nanoparticle or nano-device interventions toward later-stage NCI translational programs.

Postdoctoral researchers conducting cancer-related clinical trials in the Northern Mariana Islands can access funding through grants from the National Institutes of Health to transition into independent, tenure-track or equivalent faculty roles. This award supports early-career investigators as they move from mentored positions to launching competitive, independent oncology research programs.

The R01 grant program aims to address disparities in liver diseases and liver cancer in the United States. It supports multi-level intervention research targeting populations with significant health disparities. With deadlines spanning from February 2024 to June 2027, this initiative encourages innovative approaches to improve health outcomes in underserved communities, ultimately enhancing public health and reducing inequities in healthcare access and treatment.

The National Cancer Institute (NCI) invites applications for the validation of biomarkers and assays for cancer detection and treatment. This funding opportunity allows for biphasic or monophasic applications to support both analytical and clinical validation phases. Successful projects will leverage human specimens to develop assays that enhance cancer treatment and prevention, ensuring multidisciplinary collaboration among scientists and clinicians. This initiative aims to improve cancer management through reliable and clinically validated tools.